Risk Factors for Chronic Mastitis in Morocco and Egypt

Chronic mastitis is a prolonged inflammatory breast disease, and little is known about its etiology. We identified 85 cases and 112 controls from 5 hospitals in Morocco and Egypt. Cases were women with chronic mastitis (including periductal, lobular, granulomatous, lymphocytic, and duct ectasia with...

Full description

Bibliographic Details
Main Authors: Oltean, Hanna N., Soliman, Amr S., Omar, Omar S., Youssef, Tamer F., Karkouri, Mehdi, Abdel-Aziz, Azza, Hablas, Ahmad, Blachley, Taylor, Tahri, Ali, Merajver, Sofia D.
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847959/
id pubmed-3847959
recordtype oai_dc
spelling pubmed-38479592013-12-10 Risk Factors for Chronic Mastitis in Morocco and Egypt Oltean, Hanna N. Soliman, Amr S. Omar, Omar S. Youssef, Tamer F. Karkouri, Mehdi Abdel-Aziz, Azza Hablas, Ahmad Blachley, Taylor Tahri, Ali Merajver, Sofia D. Research Article Chronic mastitis is a prolonged inflammatory breast disease, and little is known about its etiology. We identified 85 cases and 112 controls from 5 hospitals in Morocco and Egypt. Cases were women with chronic mastitis (including periductal, lobular, granulomatous, lymphocytic, and duct ectasia with mastitis). Controls had benign breast disease, including fibroadenoma, benign phyllodes, and adenosis. Both groups were identified from histopathologically diagnosed patients from 2008 to 2011, frequency-matched on age. Patient interviews elicited demographic, reproductive, breastfeeding, and clinical histories. Cases had higher parity than controls (OR = 1.75, 1.62–1.90) and more reported history of contraception use (OR = 2.73, 2.07–3.61). Cases were less likely to report wearing a bra (OR = 0.56, 0.47–0.67) and less often used both breasts for breastfeeding (OR = 4.40, 3.39–5.72). Chronic mastitis cases were significantly less likely to be employed outside home (OR = 0.71, 0.60–0.84) and more likely to report mice in their households (OR = 1.63, 1.36–1.97). This is the largest case-control study reported to date on risk factors for chronic mastitis. Our study highlights distinct reproductive risk factors for the disease. Future studies should further explore these factors and the possible immunological and susceptibility predisposing conditions. Hindawi Publishing Corporation 2013 2013-11-14 /pmc/articles/PMC3847959/ /pubmed/24327928 http://dx.doi.org/10.1155/2013/184921 Text en Copyright © 2013 Hanna N. Oltean et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Oltean, Hanna N.
Soliman, Amr S.
Omar, Omar S.
Youssef, Tamer F.
Karkouri, Mehdi
Abdel-Aziz, Azza
Hablas, Ahmad
Blachley, Taylor
Tahri, Ali
Merajver, Sofia D.
spellingShingle Oltean, Hanna N.
Soliman, Amr S.
Omar, Omar S.
Youssef, Tamer F.
Karkouri, Mehdi
Abdel-Aziz, Azza
Hablas, Ahmad
Blachley, Taylor
Tahri, Ali
Merajver, Sofia D.
Risk Factors for Chronic Mastitis in Morocco and Egypt
author_facet Oltean, Hanna N.
Soliman, Amr S.
Omar, Omar S.
Youssef, Tamer F.
Karkouri, Mehdi
Abdel-Aziz, Azza
Hablas, Ahmad
Blachley, Taylor
Tahri, Ali
Merajver, Sofia D.
author_sort Oltean, Hanna N.
title Risk Factors for Chronic Mastitis in Morocco and Egypt
title_short Risk Factors for Chronic Mastitis in Morocco and Egypt
title_full Risk Factors for Chronic Mastitis in Morocco and Egypt
title_fullStr Risk Factors for Chronic Mastitis in Morocco and Egypt
title_full_unstemmed Risk Factors for Chronic Mastitis in Morocco and Egypt
title_sort risk factors for chronic mastitis in morocco and egypt
description Chronic mastitis is a prolonged inflammatory breast disease, and little is known about its etiology. We identified 85 cases and 112 controls from 5 hospitals in Morocco and Egypt. Cases were women with chronic mastitis (including periductal, lobular, granulomatous, lymphocytic, and duct ectasia with mastitis). Controls had benign breast disease, including fibroadenoma, benign phyllodes, and adenosis. Both groups were identified from histopathologically diagnosed patients from 2008 to 2011, frequency-matched on age. Patient interviews elicited demographic, reproductive, breastfeeding, and clinical histories. Cases had higher parity than controls (OR = 1.75, 1.62–1.90) and more reported history of contraception use (OR = 2.73, 2.07–3.61). Cases were less likely to report wearing a bra (OR = 0.56, 0.47–0.67) and less often used both breasts for breastfeeding (OR = 4.40, 3.39–5.72). Chronic mastitis cases were significantly less likely to be employed outside home (OR = 0.71, 0.60–0.84) and more likely to report mice in their households (OR = 1.63, 1.36–1.97). This is the largest case-control study reported to date on risk factors for chronic mastitis. Our study highlights distinct reproductive risk factors for the disease. Future studies should further explore these factors and the possible immunological and susceptibility predisposing conditions.
publisher Hindawi Publishing Corporation
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847959/
_version_ 1612033217631617024